{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:52:07Z","timestamp":1785498727549,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.jpeds.2004.01.051","type":"journal-article","created":{"date-parts":[[2004,5,12]],"date-time":"2004-05-12T06:26:10Z","timestamp":1084343170000},"page":"S20-S26","source":"Crossref","is-referenced-by-count":86,"special_numbering":"S","title":["Fabry disease in childhood"],"prefix":"10.1016","volume":"144","author":[{"given":"Robert J","family":"Desnick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roscoe O","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2004.01.051_BIB1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry's disease: ceramidetrihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB2","series-title":"Metabolic and molecular bases of inherited disease","first-page":"3733","article-title":"Alpha-galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB3","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB4","first-page":"67","article-title":"Angiokeratoma corporis diffusum\u2014Fabry's disease","volume":"34","author":"Colombi","year":"1967","journal-title":"Helv Med Acta"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000169023","article-title":"Novel frameshift mutation in a heterozygous woman with Fabry disease and end-stage renal failure","volume":"16","author":"Van Loo","year":"1996","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM199801293380611","article-title":"X inactivation in females with X-linked disease","volume":"338","author":"Puck","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB9","first-page":"203","article-title":"Correction of enzymatic deficiencies by renal transplantation: Fabry's disease","volume":"72","author":"Desnick","year":"1972","journal-title":"Surgery"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJM199102073240607","article-title":"An atypical variant of Fabry's disease with manifestations confined to the myocardium","volume":"324","author":"von Scheidt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","article-title":"Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype","volume":"64","author":"Nakao","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB13","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/bmj.297.6653.872","article-title":"Anderson-Fabry disease","volume":"297","author":"Morgan","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1073\/pnas.97.1.365","article-title":"Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease","volume":"97","author":"Schiffmann","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/318809","article-title":"A phase 1\/2 clinical trial of enzyme replacement in Fabry disease: pharmacokinetic, substrate clearance, and safety studies","volume":"68","author":"Eng","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB16","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2014replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2377-2-4","article-title":"Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease","volume":"2","author":"Moore","year":"2002","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB19","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1001\/jama.284.21.2771","article-title":"Clinical features of and recent advances in therapy for Fabry disease","volume":"284","author":"Brady","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB20","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1212\/WNL.39.4.598","article-title":"Carbamazepine in Fabry's disease: effective analgesia with dose-dependent exacerbation of autonomic dysfunction","volume":"39","author":"Filling-Katz","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00006231-199809000-00009","article-title":"Gastrointestinal symptoms and delayed gastric emptying in Fabry's disease: response to metoclopramide","volume":"19","author":"Argoff","year":"1998","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB22","first-page":"246","article-title":"Gastrointestinal structure and function in Fabry's disease","volume":"76","author":"Sheth","year":"1981","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB23","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1007\/BF01540061","article-title":"Anorexia, weight loss, and diarrhea as presenting symptoms of angiokeratoma corporis diffusum (Fabry-Anderson's disease)","volume":"34","author":"Nelis","year":"1989","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB24","first-page":"157","article-title":"Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes: alpha-galactosidase activities in plasma, serum, urine, and leukocytes","volume":"81","author":"Desnick","year":"1973","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1126\/science.172.3979.174","article-title":"Fabry's disease: antenatal detection","volume":"172","author":"Brady","year":"1971","journal-title":"Science"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB26","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB27","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/WNL.23.8.871","article-title":"Relief of pain of Fabry's disease by diphenylhydantoin","volume":"23","author":"Lockman","year":"1973","journal-title":"Neurology"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB28","first-page":"704","article-title":"[Fabry's disease: carbamazepine therapy in acrodyniform syndrome]","volume":"34","author":"Lenoir","year":"1977","journal-title":"Arch Fr Pediatr"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1051\/jbio\/2002196020183","article-title":"[Fabry's disease (alpha-galactosidase-A deficiency): recent therapeutic innovations]","volume":"196","author":"Germain","year":"2002","journal-title":"J Soc Biol"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB30","first-page":"7","article-title":"[Fetal pathology in Fabry's disease and mucopolysaccharidosis type I]","volume":"34","author":"Elleder","year":"1998","journal-title":"Cesk Patol"},{"issue":"Suppl 1","key":"10.1016\/j.jpeds.2004.01.051_BIB31","first-page":"115","article-title":"Therapy for Fabry disease: comparison of agalsidase alpha and beta enzyme preparations","volume":"25","author":"Linthorst","year":"2002","journal-title":"J Inher Metab Dis"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/glycob\/cwg034","article-title":"Biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry disease","volume":"13","author":"Lee","year":"2003","journal-title":"Glycobiology"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB33","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","article-title":"Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy","volume":"62","author":"Thurberg","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.jpeds.2004.01.051_BIB34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am J Med"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347604000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347604000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T08:56:06Z","timestamp":1549702566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347604000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0022347604000964"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2004.01.051","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}